Iroko Pharmaceuticals LLC acquires Merck & Co Inc-Aggrastat from Merck & Co Inc
US - Iroko Pharmaceuticals LLC acquired the Aggrastat cardiovascular product of Merck & Co Inc, a manufacturer and developer of pharmaceuticals. Terms were not disclosed.…
Deal Information
Credit & Investment Research
Market Research
News
Merck Sharp and Dohme Corp. Mergers & Acquisitions